EVALUATION OF NON-ADHERENCE TO ANTITUBERCULAR DRUGS AMONG TUBERCULOSIS PATIENTS: A PROSPECTIVE STUDY
Objective: The objective of present study was to examine the non-adherence among tuberculosis patients to antitubercular drugs and the factors associated with non-adherence.
Methods: Prospective observational study was conducted in department of pharmacology Government Medical College, Kathua in collaboration with the district tuberculosis centre, Kathua for a period of four months. TB Patients on treatment for last 8 w were included in the study. The pre validated questionnaire was provided to patients and their responses were analysed. Morisky’s Medication Adherence Scale (MMAS-4) was used to assess adherence/non-adherence to antitubercular drugs.
Results: Total 72 patients were included in trial and out of which 60(83.33%) were males and12 (16.66%) were females and the maximum were between 40-50y (38%) of age, mostly illiterate (50%) and from lower socioeconomic status (38%). Out of 60 male patients, 48(80%) showed adherence to anti-tuberculosis drugs, while remaining 12(20%) were non-adherent. Whereas 10females (83%) were adherent and 2 (16.66%) were non-adherent. Forgetfulness (42%), followed by illiteracy (21.4%) and longer distance from health institute (14%) were main reasons for non-adherence.
Conclusion: Present study has shown non-adherence is maximum among males, illiterate, low socioeconomic group, longer distance from the health institution.
2. Ch K. Factor affecting compliance to tuberculosis treatment in Andra Kanvango region in Nambia. Journal of compliance to TB treatment; 2010.
3. Hawn TR, Day TA, Scriba TJ, Hatherill M, Hanekom WA, Evans TG, et al. Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev 2014;78:650–71.
4. Organization, World Health. Implementing the WHO Stop TB Strategy: a handbook for national TB control programmes; 2008. p. 179.
5. Harris RE. Epidemiology of chronic disease: global perspectives. Burlington, MA: Jones and Bartlett Learning; 2013. p. 682.
6. WHO treatment of tuberculosis guidelines. In: 4th edition ed: world health organization; 2010.
7. World health organisation, global tuberculosis control. Surveillance, Planning, Financing. 170, Geneva; 2004.
8. Tahao Glu K, Torun T, Sevim T, Atac G, Kir A, Karasulu L, Kapakli N. The treatment of multidrug resistant tuberculosis in turkey. N Engl J Med 2001;345:170-4.
9. McDonnell M, Turner J, Weaver MT. Anticedents of adherence to antituberculosis therapy. Public Health Nurse 2001;18:392-400.
10. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber Lung Dis 1993;74:32-7.
11. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
12. Santra G. Assessment of adherence to cardiovascular medicines in rural population: an observational study in patients attending a tertiary care hospital; Indian J Pharmacol 2015;47:600-4.
13. Geethalakshmi RG, Dsouza MJ Ashok. Adherence to non tuberculosis treatment among patients in urban field practice area of Medical College, Devangere, Karnataka, a qualitative study. Int J Community Med Public Health 2019;6:255-8.
14. A Aashutosh, N Shubhangi, I Manouj. A study on factors associated with non adherence to ATT among pulmonary tuberculosis patients under RNTCP. Int J Med Sci Clin Intervention 2017;4:2759-63.
15. G Harshul, P Goeka, S Esha, S Hrvy, D Harmony, P Harsh. Across sectional study to assess the non adherence to anti tuberculosis treatment and determinant factors among patients with pulmonary tuberculosis. GCSMC J Med Sci 2017;VI:22-6.
16. Hanumaiah V, Ranganath DD, Kakkuppi N. Assessment of adherence to antituberculosis medication for successful implementation of revised national tuberculosis programme at a tertiary care hospital. Shimoga: a cross section observational study. Int J Basic Clin Pharmacol 2019;8:2361-6.
This work is licensed under a Creative Commons Attribution 4.0 International License.